Skip to main content

Advertisement

SpringerLink
Log in

Quantification of serum SOX2 DNA with FQ-PCR potentially provides a diagnostic biomarker for lung cancer

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

Sex-determining region Y-box 2 (SOX2), as a subunit of transcription and reprogramming factor, plays a critical role in the development and progression of many malignancies, including lung cancer through gene amplification. In the present study, we aimed to quantify the levels of serum SOX2 DNA, analyze its diagnostic value and compare it with existing clinical parameters in lung cancer, and purpose to provide a novel tumor marker for lung cancer. Serum DNA was extracted from 94 lung cancer patients, 10 benign lung diseases, and 30 healthy volunteers, and then the levels of SOX2 DNA were quantified using real-time fluorescent quantitative polymerase chain reaction (FQ-PCR). The data were analyzed by statistical software SPSS14.0. The present results show that serum SOX2 DNA level in lung cancer group was higher compared to the levels in benign lung diseases group (u = 102.0, p < 0.001) or healthy group (u = 140.0, p < 0.001), and it was closely associated with TNM stage, histopathological type, and tumor size (p = 0.031, p = 0.012, and p = 0.010, respectively). However, serum SOX2 DNA levels of lung cancer patients were not associated with age, gender, smoking status, lymph node metastasis, or tumor differentiation (p > 0.05). ROC curve showed a sensitivity of 78.9 % and a specificity of 82.5 % for the ability of serum SOX2 DNA to detect lung cancer at the cutoff value of 1,078.3 copies/ul. Furthermore, we assessed the associations of serum SOX2 levels with clinical existing lung tumor markers, such as squamous cell carcinoma antigen, cytokeratin fragment 21-1, and neuron-specific enolase. The sensitivity was increased from 24.9, 66.1, and 39.1 to 84.2, 92.8, and 87.5 %, respectively, by the combination of serum SOX2 DNA. Taken together, quantification of serum SOX2 DNA by FQ-PCR may serve as a novel accessory diagnostic tool for the clinical screening and detection of lung cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

CAN:

Circulating nucleic acids

CYFRA21-1:

Cytokeratin fragment 21-1

FQ-PCR:

Real-time fluorescent quantitative polymerase chain reaction

NSCLC:

Nonsmall cell lung cancer

NSE:

Neuron-specific enolase

SCC:

Squamous cell carcinoma

SOX2:

Sex-determining region Y-box 2

References

  1. Kato H, Ichinose Y, Ohta M, Hata E, Tsubota N, Tada H, Watanabe Y, Wada H, Tsuboi M, Hamajima N, Ohta M. A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung. N Engl J Med. 2004;350:1713–21.

    Article  CAS  PubMed  Google Scholar 

  2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.

    Article  PubMed  Google Scholar 

  3. Bendtsen C, Kietzmann M, Korn R, Mozley PD, Schmidt G, Binnig G. X-ray computed tomography: semiautomated volumetric analysis of late-stage lung tumors as a basis for response assessments. Int J Biomed Imaging. 2011;2011:361589–600.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  4. Lam B, Lam SY, Wong MP, Ooi CG, Fong DY, Lam DC, Lai AY, Tam CM, Pang CB, Ip MS, Lam WK. Sputum cytology examination followed by autofluorescence bronchoscopy: a practical way of identifying early stage lung cancer in central airway. Lung Cancer. 2009;64:289–94.

    Article  PubMed  Google Scholar 

  5. Leon SA, Shapiro B, Sklaroff DM, Yaros MJ. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res. 1977;37:646–50.

    CAS  PubMed  Google Scholar 

  6. Schwarzenbach H, Hoon DS, Pantel K. Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer. 2011;11:426–37.

    Article  CAS  PubMed  Google Scholar 

  7. Gontan C, de Munck A, Vermeij M, Grosveld F, Tibboel D, Rottier R. Sox2 is important for two crucial processes in lung development: branching morphogenesis and epithelial cell differentiation. Dev Biol. 2008;317:296–309.

    Article  CAS  PubMed  Google Scholar 

  8. Graham V, Khudyakov J, Ellis P, Pevny L. SOX2 functions to maintain neural progenitor identity. Neuron. 2003;39:749–65.

    Article  CAS  PubMed  Google Scholar 

  9. Rudin CM, Durinck S, Stawiski EW, Poirier JT, Modrusan Z, Shames DS, Bergbower EA, Guan Y, Shin J, Guillory J, Rivers CS, Foo CK, Bhatt D, Stinson J, Gnad F, Haverty PM, et al. Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer. Nat Genet. 2012;44:1111–6.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  10. Lengerke C, Fehm T, Kurth R, Neubauer H, Scheble V, Müller F, Schneider F, Petersen K, Wallwiener D, Kanz L, Fend F, Perner S, Bareiss PM, Staebler A. Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma. BMC Cancer. 2011;11:42–51.

    Article  PubMed Central  PubMed  Google Scholar 

  11. Sun C, Sun L, Li Y, Kang X, Zhang S, Liu Y. Sox2 expression predicts poor survival of hepatocellular carcinoma patients and it promotes liver cancer cell invasion by activating slug. Med Oncol. 2013;30:503–13.

    Article  PubMed  Google Scholar 

  12. Hussenet T, du Manoir S. SOX2 in squamous cell carcinoma: amplifying a pleiotropic oncogene along carcinogenesis. Cell Cycle. 2010;9:1480–6.

    Article  CAS  PubMed  Google Scholar 

  13. Hussenet T, Dali S, Exinger J, Monga B, Jost B, Dembelé D, Martinet N, Thibault C, Huelsken J, Brambilla E. du Manoir S.SOX2 is an oncogene activated by recurrent 3q26.3 amplification in human lung squamous cell carcinomas. PLoS ONE. 2010;5:e8960.

    Article  PubMed Central  PubMed  Google Scholar 

  14. Lu Y, Futtner C, Rock JR, Xu X, Whitworth W, Hogan BL, Onaitis MW. Evidence that SOX2 overexpression is oncogenic in the lung. PLoS ONE. 2010;5:e11022.

    Article  PubMed Central  PubMed  Google Scholar 

  15. Chen S, Xu Y, Chen Y, Li X, Mou W, Wang L, Liu Y, Reisfeld RA, Xiang R, Lv D. Li N.SOX2 gene regulates the transcriptional network of oncogenes and affects tumorigenesis of human lung cancer cells. PLoS ONE. 2012;7:e36326.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  16. Park SB, Seo KW, So AY, Seo MS, Yu KR, Kang SK, Kang KS. SOX2 has a crucial role in the lineage determination and proliferation of mesenchymal stem cells through Dickkopf-1 and c-MYC. Cell Death Differ. 2012;19:534–45.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  17. Tang XB, Shen XH, Li L, Zhang YF, Chen GQ. SOX2 overexpression correlates with poor prognosis in laryngeal squamous cell carcinoma. Auris Nasus Larynx. 2013;40:481–6.

    Article  PubMed  Google Scholar 

  18. Xiang R, Liao D, Cheng T, Zhou H, Shi Q, Chuang TS, Markowitz D, Reisfeld RA, Luo Y. Downregulation of transcription factor SOX2 in cancer stem cells suppresses growth and metastasis of lung cancer. Br J Cancer. 2011;104:1410–7.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  19. Züllig L, Roessle M, Weber C, Graf N, Haerle SK, Jochum W, Stoeckli SJ, Moch H, Huber GF. High sex determining region Y-box 2 expression is a negative predictor of occult lymph node metastasis in early squamous cell carcinomas of the oral cavity. Eur J Cancer. 2013;49:1915–22.

    Article  PubMed  Google Scholar 

  20. Schröck A, Göke F, Wagner P, Bode M, Franzen A, Braun M, Huss S, Agaimy A, Ihrler S, Menon R, Kirsten R, Kristiansen G, Bootz F, Lengerke C, Perner S. Sex determining region Y-box 2 (SOX2) amplification is an independent indicator of disease recurrence in sinonasal cancer. PLoS ONE. 2013;8:e59201.

    Article  PubMed Central  PubMed  Google Scholar 

  21. Li X, Wang J, Xu Z, Ahmad A, Li E, Wang Y, Qin S, Wang Q. Expression of Sox2 and Oct4 and their clinical significance in human non-small-cell lung cancer. Int J Mol Sci. 2012;13:7663–75.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  22. Ginzinger DG. Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream. Exp Hematol. 2002;30:503–12.

    Article  CAS  PubMed  Google Scholar 

  23. Yang YJ, Chen H, Huang P, Li CH, Dong ZH, Hou YL. Quantification of plasma hTERT DNA in hepatocellular carcinoma patients by quantitative fluorescent polymerase chain reaction. Clin Invest Med. 2011;34:E238–44.

    CAS  PubMed  Google Scholar 

  24. Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC. World health organization classification tumors of the lung, pleura, thymus and heart. Lyon: IARC Press; 2004. p. 10–20.

    Google Scholar 

  25. Sasaki H, Yokota K, Hikosaka Y, Moriyama S, Yano M, Fujii Y. Increased Sox2 copy number in lung squamous cell carcinomas. ExpTher Med. 2012;3:44–8.

    CAS  Google Scholar 

  26. Tarro G, Perna A, Esposito C. Early diagnosis of lung cancer by detection of tumor liberated protein. J Cell Physiol. 2005;203:1–5.

    Article  CAS  PubMed  Google Scholar 

  27. Bass AJ, Watanabe H, Mermel CH, Yu S, Perner S, Verhaak RG, Kim SY, Wardwell L, Tamayo P, Gat-Viks I, Ramos AH, Woo MS, Weir BA, Getz G, Beroukhim R, O’Kelly M, et al. SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nature Genet. 2009;41:1238–42.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  28. Wilbertz T, Wagner P, Petersen K, Stiedl AC, Scheble VJ, Maier S, Reischl M, Mikut R, Altorki NK, Moch H, Fend F, Staebler A, Bass AJ, Meyerson M, Rubin MA, Soltermann A, Lengerke C, Perner S. SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer. Mod Pathol. 2011;24:944–53.

    Article  CAS  PubMed  Google Scholar 

  29. McCaughan F, Pole JC, Bankier AT, Konfortov BA, Carroll B, Falzon M, Rabbitts TH, George PJ, Dear PH, Rabbitts PH. Progressive 3q amplification consistently targets SOX2 in preinvasive squamous lung cancer. Am J Respir Crit Care Med. 2010;182:83–91.

    Article  PubMed Central  PubMed  Google Scholar 

  30. Maier S, Wilbertz T, Braun M, Scheble V, Reischl M, Mikut R, Menon R, Nikolov P, Petersen K, Beschorner C, Moch H, Kakies C, Protzel C, Bauer J, Soltermann A, Fend F, Staebler A, Lengerke C, Perner S. SOX2 amplification is a common event in squamous cell carcinomas of different organ sites. Hum Pathol. 2011;42:1078–88.

    Article  CAS  PubMed  Google Scholar 

  31. Ji J, Zheng PS. Expression of Sox2 in human cervical carcinogenesis. Hum Pathol. 2010;41:1438–47.

    Article  CAS  PubMed  Google Scholar 

  32. Sozzi G, Conte D, Mariani L, Vullo SL, Roz L, Lombardo C, Pierotti MA, Tavecchio L. Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients. Cancer Res. 2001;61:4675–8.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This research was supported by the Natural Science Foundation of CQ CSTC (Grant No. cstc2012jjA10105), Medical Scientific Program of Chongqing Municipal Health Bureau (Grant No. 2012-2-016), and the National Clinical Key Subject Construction Project [Grant No. 2010 (305)].

Conflict of interest

There is no conflict between the authors.

Author information

Authors and Affiliations

  1. Clinical Laboratories, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China

    Yanfeng Wu, Xiao Du, Chengjun Xue, Detao Li, Qian Zheng, Xue Li & Hui Chen

Authors
  1. Yanfeng Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xiao Du
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chengjun Xue
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Detao Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Qian Zheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Xue Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hui Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hui Chen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wu, Y., Du, X., Xue, C. et al. Quantification of serum SOX2 DNA with FQ-PCR potentially provides a diagnostic biomarker for lung cancer. Med Oncol 30, 737 (2013). https://doi.org/10.1007/s12032-013-0737-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12032-013-0737-y

Keywords

Search

Navigation